Christopher G. Micetich

Biography

Mr. Micetich founded Fedora in 2012 after in-licensing a family of beta-lactamase inhibitors. Under Mr. Micetich’s leadership, these beta-lactamase inhibitors underwent optimization and preclinical development, after which they were licensed to Roche in January 2015 in a deal worth up to $750 million. Samarendra N. Maiti, Ph.D. Distinguished Scientist ​ Dr. Maiti obtained his Ph.D. from the Kalyani University, West Bengal, India in 1980. He has over 35 years of experience in medicinal & synthetic chemistry and has collaborated with large pharmaceutical companies in important therapeutic areas such as, antimicrobials, cardiovascular, CNS, and metabolic disorders.   He has written chapters in two books, written five reviews, and has 15 patents and 60 publications. During the 35 years of his research career Dr. Maiti was involved in three antimicrobial projects that successfully produced three clinical candidates, one of which is already in the market, and two that are in development. ​ Earlier, Mr. Micetich was the chief operating officer at SynPhar Laboratories Inc., a joint venture with Taiho Pharmaceuticals Inc. dedicated to early drug discovery in the area of infectious diseases. At SynPhar, he was responsible for all aspects of administration including business development, international affairs, and strategic planning, playing an instrumental role in building the operation to 65 full-time permanent employees. In 1998, Mr. Micetich founded an independent contract chemistry company called DrisCorp Inc. that performed early stage lead optimization, process development and custom synthesis.   In 1999, Mr. Micetich co-orchestrated an acquisition of all assets of SynPhar from their majority Japanese partner, Taiho, which were merged into NAEJA Pharmaceutical Inc., a newly created, privately controlled company. In October of that year, he merged DrisCorp into NAEJA, a contract research organization with a specialty in infectious diseases.   In addition to his career in specialty pharmaceuticals, Mr. Micetich founded Windjammer Java Roasters Inc., a specialty coffee roasting company and Brass Dome Ventures Ltd., a management and business consultancy.   Mr. Micetich graduated from the University of Alberta in 1986

Research Interest

Clinical Pharmacy  Pharmaceutical Administration Medicinal Chemistry  Drug Discovery and Development  Pharmaceutical Technology and Biopharmaceutics Pharmaceutical Analysis